Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ayala Pharmaceuticals - 16 Year Stock Price History | ADXS

Historical daily share price chart and data for Ayala Pharmaceuticals since 2005 adjusted for splits and dividends. The latest closing stock price for Ayala Pharmaceuticals as of December 22, 2021 is 0.24.
  • The all-time high Ayala Pharmaceuticals stock closing price was 937.50 on July 29, 2005.
  • The Ayala Pharmaceuticals 52-week high stock price is 0.00, which is -100% above the current share price.
  • The Ayala Pharmaceuticals 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average Ayala Pharmaceuticals stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ayala Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 0.5525 0.4170 1.4100 0.2400 0.2400 -31.17%
2020 0.6037 1.0900 1.3000 0.2840 0.3487 -59.34%
2019 2.4578 4.4250 7.6050 0.2485 0.8577 -69.91%
2018 22.4883 46.5000 48.6000 2.7825 2.8500 -93.31%
2017 97.3028 112.3500 144.0000 42.3000 42.6000 -60.34%
2016 134.4000 141.1500 239.7000 81.9000 107.4000 -28.83%
2015 221.2351 126.3000 431.5500 105.3000 150.9000 25.59%
2014 54.3221 61.2000 135.0000 37.6500 120.1500 88.92%
2013 97.5673 56.2500 262.5000 40.5000 63.6000 13.07%
2012 175.2000 300.0000 318.7500 56.2500 56.2500 -81.25%
2011 279.3155 225.0000 450.0000 225.0000 300.0000 33.33%
2010 295.0893 243.7500 431.2500 187.5000 225.0000 -14.29%
2009 159.6726 37.5000 318.7500 37.5000 262.5000 600.00%
2008 151.6749 318.7500 318.7500 24.3750 37.5000 -88.24%
2007 429.9801 375.0000 806.2500 262.5000 318.7500 -5.56%
2006 407.0468 393.7500 562.5000 262.5000 337.5000 -14.29%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.006B $0.000B
Ayala Pharmaceuticals Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. It also involved in developing proprietary Lm-based antigen delivery products for patients suffering from more common cancers. The company's lead candidates under development are AL102 and ADXS-504. Ayala Pharmaceuticals Inc., formerly known as Advaxis Inc., is based in REHOVOT, Israel.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.985B 28.76
Chugai Pharmaceutical (CHGCY) Japan $54.581B 23.70
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.986B 19.80
Astellas Pharma (ALPMY) Japan $16.902B 23.95
Shionogi (SGIOY) Japan $14.275B 12.35
Neurocrine Biosciences (NBIX) United States $13.233B 54.96
Sandoz Group AG (SDZNY) $13.171B 0.00
United Therapeutics (UTHR) United States $10.907B 11.68
Catalent (CTLT) United States $10.095B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.501B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.861B 6.96
Ionis Pharmaceuticals (IONS) United States $6.055B 0.00
Revolution Medicines (RVMD) United States $5.970B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Madrigal Pharmaceuticals (MDGL) United States $4.636B 0.00
Alpine Immune Sciences (ALPN) United States $4.228B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.933B 0.00
Indivior (INDV) United States $2.673B 12.43
Evotec AG (EVO) Germany $2.484B 0.00
Summit Therapeutics (SMMT) United States $2.484B 0.00
Corcept Therapeutics (CORT) United States $2.421B 24.62
Dyne Therapeutics (DYN) United States $2.123B 0.00
PTC Therapeutics (PTCT) United States $1.937B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.834B 18.95
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.776B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.741B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.673B 9.91
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.581B 27.66
Ardelyx (ARDX) United States $1.561B 0.00
4D Molecular Therapeutics (FDMT) United States $1.368B 0.00
Pacira BioSciences (PCRX) United States $1.249B 12.44
Ironwood Pharmaceuticals (IRWD) United States $1.235B 11.60
Soleno Therapeutics (SLNO) United States $1.227B 0.00
Ocular Therapeutix (OCUL) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.158B 7.12
Xencor (XNCR) United States $1.156B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.106B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.950B 0.00
Sage Therapeutics (SAGE) United States $0.939B 0.00
Cronos Group (CRON) Canada $0.932B 0.00
Cassava Sciences (SAVA) United States $0.909B 0.00
ARS Pharmaceuticals (SPRY) United States $0.886B 0.00
Relay Therapeutics (RLAY) United States $0.884B 0.00
Enliven Therapeutics (ELVN) United States $0.875B 0.00
USANA Health Sciences (USNA) United States $0.831B 13.09
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.723B 0.00
Savara (SVRA) United States $0.713B 0.00
Silence Therapeutics (SLN) United Kingdom $0.636B 0.00
Siga Technologies (SIGA) United States $0.635B 9.40
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Verve Therapeutics (VERV) United States $0.597B 0.00
Korro Bio (KRRO) United States $0.589B 0.00
OmniAb (OABI) United States $0.565B 0.00
Altimmune (ALT) United States $0.533B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.501B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Larimar Therapeutics (LRMR) United States $0.462B 0.00
Tourmaline Bio (TRML) United States $0.458B 0.00
Heron Therapeutics (HRTX) United States $0.440B 0.00
Harrow (HROW) United States $0.435B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.432B 0.00
Lexeo Therapeutics (LXEO) United States $0.403B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.367B 0.00
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Nature's Sunshine Products (NATR) United States $0.356B 19.91
ESSA Pharma (EPIX) Canada $0.329B 0.00
Fractyl Health (GUTS) United States $0.327B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.325B 0.00
Lyra Therapeutics (LYRA) United States $0.323B 0.00
Metagenomi (MGX) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.297B 0.00
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Black Diamond Therapeutics (BDTX) United States $0.278B 0.00
Adherex Technologies (FENC) United States $0.278B 0.00
Nektar Therapeutics (NKTR) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.273B 0.00
Prelude Therapeutics (PRLD) United States $0.270B 0.00
Nanobiotix S.A (NBTX) France $0.260B 0.00
Foghorn Therapeutics (FHTX) United States $0.257B 0.00
Xeris Biopharma Holdings (XERS) United States $0.253B 0.00
Avita Medical (RCEL) United States $0.249B 0.00
Telomir Pharmaceuticals (TELO) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.225B 0.00
Acrivon Therapeutics (ACRV) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.207B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.191B 0.00
MediWound (MDWD) Israel $0.174B 0.00
Regulus Therapeutics (RGLS) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.156B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.150B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Inotiv (NOTV) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.53
GlycoMimetics (GLYC) United States $0.139B 0.00
Relmada Therapeutics (RLMD) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.87
ProPhase Labs (PRPH) United States $0.133B 0.00
FibroGen (FGEN) United States $0.128B 0.00
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Eliem Therapeutics (ELYM) United States $0.126B 0.00
OptiNose (OPTN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Vivani Medical (VANI) United States $0.106B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
AlloVir (ALVR) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Journey Medical (DERM) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 6.12
Tempest Therapeutics (TPST) United States $0.074B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Mural Oncology (MURA) $0.066B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.066B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
Gain Therapeutics (GANX) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
JanOne (JAN) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Nutriband (NTRB) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.031B 0.00
Viracta Therapeutics (VIRX) United States $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.027B 0.00
Lipocine (LPCN) United States $0.025B 0.00
DURECT (DRRX) United States $0.024B 0.00
Addex Therapeutics (ADXN) Switzerland $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.40
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.08
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Finch Therapeutics (FNCH) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.92
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 46.73